LONDON—Hematopoietic stem cells are not displaced and depleted by malignant cells in patients with acute myeloid leukaemia but merely put to sleep, according to research from London published in PNAS Early Edition. Professor John Gribben from Barts Cancer Institute in London discusses their finding and explains how this gives new opportunities for treating AML.
You may also like...
Advanced, unresectable melanoma: survival rates at five years doubled with ipilimumab therapy 26 Oct, 2013 Combining Checkpoint Inhibition With Other Therapies for Lung Cancer 22 Apr, 2015 Audio Journal of Oncology in Advance – October 1st, 2006 1 Oct, 2006 Audio Journal of Oncology in Advance – May 1st, 2007 – reporting from: American Association for Cancer Research 14-18 April, 2007 Los Angeles 2 May, 2007
- Previous story Chimeric antigen receptor T-cell therapy rescues kids with relapsing acute lymphoblastic leukaemia
- Next story Normal stem cells are not depleted in acute myeloid leukaemia and could be targeted therapeutically
- Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
- First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
- Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
- Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
- MMR vaccine’s non-specific effects: adherence to recommended vaccination schedules protects children against non-vaccination-specific infections tooFebruary 28, 2014